34 related articles for article (PubMed ID: 38450826)
1. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
2. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
[TBL] [Abstract][Full Text] [Related]
4. Study of Vulvovaginal Atrophy and Genitourinary Syndrome of Menopause and Its Impact on the Quality of Life of Postmenopausal Women in Central India.
Ulhe SC; Acharya N; Vats A; Singh A
Cureus; 2024 Feb; 16(2):e54802. PubMed ID: 38529421
[TBL] [Abstract][Full Text] [Related]
5. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
[TBL] [Abstract][Full Text] [Related]
6. The effects of a real-time temperature monitoring non-ablative monopolar radiofrequency technology on vulvovaginal atrophy symptoms in postmenopausal Chinese women.
Cheng V; Chi-Shing WT; Lee A; Lee R
J Cosmet Dermatol; 2024 Jun; 23(6):2030-2043. PubMed ID: 38450826
[TBL] [Abstract][Full Text] [Related]
7. Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.
Nappi RE; Martini E; Cucinella L; Martella S; Tiranini L; Inzoli A; Brambilla E; Bosoni D; Cassani C; Gardella B
Front Endocrinol (Lausanne); 2019; 10():561. PubMed ID: 31496993
[TBL] [Abstract][Full Text] [Related]
8. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
9. Review of non-invasive vulvovaginal rejuvenation.
Photiou L; Lin MJ; Dubin DP; Lenskaya V; Khorasani H
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):716-726. PubMed ID: 31714632
[TBL] [Abstract][Full Text] [Related]
10. Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study.
Zhu Y; Wei J; Yang X; Zhu W; Zhang W
BMC Womens Health; 2022 Dec; 22(1):558. PubMed ID: 36585649
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Rejuvenation: A Retrospective Review of Lasers and Radiofrequency Devices.
Juhász MLW; Korta DZ; Mesinkovska NA
Dermatol Surg; 2021 Apr; 47(4):489-494. PubMed ID: 33165070
[TBL] [Abstract][Full Text] [Related]
12. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion.
Liu JH; Bernick B; Mirkin S
Expert Opin Drug Deliv; 2020 Nov; 17(11):1573-1581. PubMed ID: 32877254
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
